Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

The Cloud Imperative in Life Sciences - Accenture

Our report gives guidance on accelerating the move to the cloud create value for life sciences companies.

Les commentaires sont fermés

  • Identifiez-vous pour voir les commentaires

The Cloud Imperative in Life Sciences - Accenture

  1. 1. The cloud imperative in life sciences
  2. 2. Why cloud? Why now? | Moving to the cloud gives life sciences companies an opportunity to deliver more effective treatments to patients in a more economically viable way. | COVID-19 has created a new inflection point and opportunity to realize the impact a move to the cloud can have on their business. | Two-thirds of life sciences companies said they haven’t achieved the results expected of their cloud initiatives to date. The cloud is one of the most value-creating technologies of our time. It is the foundationfor the digitaltransformation that is driving profound changes in how businesses operate, compete and create value for all their stakeholders.
  3. 3. For life sciences companies, the cloud’s virtue is not just about running a more streamlined business, lowering costs and computing on demand. It is about the ability to unlock data, collaborate better across the ecosystem,create more meaningful patient and healthcare provider engagement and transform their culture to embrace these new ways of working.
  4. 4. State of cloud in Life Sciences today Figure 3: Extent to which life sciences respondents reportthey havefully achieved their expected cloud outcomes. 34% 39% 46% 29% 33% 24% Report fully achievingtheir expected cloud outcomes Cost Fully achieved Speed Fully achieved Business Enablement Fully achieved Improved Service Levels Fully achieved Resiliency/ Business Continuity Fully achieved Lost in cloud? Navigating to maximumvalue. Accenture 2020 Very few life sciences companies are taking a “cloud first” approachwhere the cloud is primary and prioritized, extended beyond the IT organizationandembraced by the whole organization. Just adoptingcloud technology or moving parts of the business to the cloud does not ensure business value.
  5. 5. The next major business disruptionwill see those companies who overcame these obstacles with a mature cloud strategy able to respond in an agile, cost-effective fashion. Five obstacles to cloud adoption in life sciences 1. Competition for talent leaves the industry at a disadvantage to access the best human capital. 2. Margin decline is so slow that it can be hard to see, especially when profits are still high. 3. Data silos, different systems and security concerns add complexity and risk. 4. Different groups have the responsibility and funding for digital and cloud resulting in different incentives and ways of measuring success. 5. Regulatory policies are slow and complex compared to the more agile and faster IT methods that cloud enables.
  6. 6. An intelligentcloudjourney needs to balance speed and value. Each company should start with defining the value, mapping out the journey and determininghow cloud will enable the overallbusiness strategy and ambition.For life sciences companies, that means adopting and adhering to the following key strategies: Moving to action | Embrace cloud as a CEO priority | Build cross-functional teams and partnerships | Develop an innovation spirit | Unify responsibility and success metrics | Investin developing talent with digital skills | Reshape the regulatory environment
  7. 7. Reaching new heights and outcomes To support the innovationand pace of New Science with the cloud, life sciences companies need a digitalcapabilitywith speed and agilitythat can support acceleratedcycles of new treatments and services. Moving to the cloud enables this to happenin multipleways: 1 2 3 Free the data Managing and measuring patient outcomes is impossiblewithout freeing patient data while securely accessing it across thecompany and partners. Unify the value chain Making the whole organization more accessible and open can enable everything fromattracting top talent to advancing the discovery of New Science. Ignite growth The cloud allows companies to scale computational resources to the volume of genomic data being analyzed for cutting-edge therapies in development.
  8. 8. Cloud isn’t some future aspiration—it’san urgent mandate at the heart of the business. COVID-19 has created an unprecedentedwake-up call and an opportunityto embrace the promise of cloud in life sciences. It takes courage and investment to shape the near-term progress of cloud technology in life sciences. It’s a big lift, but those companies that do will lead the New Science revolutionwith unparalleledresilience,agility, adaptability andscalability.They will empower their workforce, digitallytransform their company and improve their abilityto deliver better patientoutcomes. The view from above
  9. 9. Let’s talk Geoff Schmidt Managing Director Cloud First Life Sciences geoffrey.d.schmidt@accenture.com Followus: